Ekso Bionics to Present at the H.C. Wainwright Global Investment Conference

RICHMOND, Calif., May 17, 2022 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO), an industry leader in exoskeleton technology for medical and industrial use, today announced that management will present at the H.C. Wainwright Global Investment Conference taking place May 23-26, 2022.

The pre-recorded presentation will be available to view on-demand as of 4:00 AM PT / 7:00 AM ET, Tuesday, May 24, 2022 throughout the entirety of the conference and on the investor section of the Company’s website at www.eksobionics.com.

About Ekso Bionics® Ekso Bionics® is a leading developer of exoskeleton solutions that amplify human potential by supporting or enhancing strength, endurance, and mobility across medical and industrial applications. Founded in 2005, the Company continues to build upon its industry-leading expertise to design some of the most cutting-edge, innovative wearable robots available on the market. Ekso Bionics is the only exoskeleton company to offer technologies that range from helping those with paralysis to stand up and walk, to enhancing human capabilities on job sites across the globe. Ekso Bionics is headquartered in the San Francisco Bay Area and is listed on the Nasdaq Capital Market under the symbol “EKSO.” For more information, visit: www.eksobionics.com or follow @EksoBionics on Twitter.

Investor Contact:David Carey212-867-1768[email protected] 

You May Also Be Interested In

• SabPaisa Partners with AccuKnox for Zero Trust AI-Powered Cloud Security to Secure Its Payments Platform
• Wilder Intelligence Inc. Launches Wilder AI: The High-Stakes Research Platform Where Accuracy Is the Baseline, Not the Upgrade
• Wuyi County Highlights Industrial R&D Strength as Local Motorcycle Enterprise Wins Taklimakan Rally Champion Title